The ULTIMATE-DAPT (One-Month Ticagrelor Monotherapy After PCI in Acute Coronary Syndromes) trial data demonstrated that, in patients with acute coronary syndrome who underwent percutaneous coronary ...

Safety and outcomes are improving at Seattle-based Swedish Heart & Vascular Institute thanks to two rapid response teams for high acuity issues: the cardiogenic shock team and the pulmonary ...

The goal of the trial was to evaluate treatment with an Impella percutaneous left ventricular assist device (LVAD) compared with an intra-aortic balloon pump (IABP) in patients with cardiogenic ...

Get Instant Summarized Text (Gist) For patients with advanced emphysema, lung volume reduction surgery (LVRS) results in lower mortality and morbidity compared to endobronchial valve placement ...

Hayanga, and after the valves received FDA approval in 2018, their use and popularity has grown rapidly as a treatment for patients with conditions like chronic obstructive pulmonary disorder (COPD).